125 results
Page 5 of 7
6-K
EX-99.2
t3f7d
30 Jun 20
Result of Annual General Meeting
4:07pm
6-K
EX-99.3
bxptdb28hb fixyf
30 Jun 20
Result of Annual General Meeting
4:07pm
6-K
EX-99.1
a796mow
30 Jun 20
Result of Annual General Meeting
4:07pm
6-K
pm513x9ynlj
16 Jun 20
Current report (foreign)
4:13pm
6-K
EX-99.1
ftq5fkvlft7j ac8m
9 Jun 20
Publication of Circular and Notice of General Meeting
4:15pm
6-K
EX-99.1
y198974
5 Jun 20
Mereo BioPharma Announces Completion of $70 Million Private Placement
12:00am
6-K
EX-99.1
urhknkknv4ganel7
27 May 20
Notice of Annual General Meeting
7:37am
6-K
EX-99.1
13lgr4gbics5l74 xhq
22 May 20
Annual General Meeting
9:31am
6-K
EX-99.1
ob38j1v3 ez
27 Mar 20
Business Update and Directorate Change
9:09am
F-1/A
gzyflj524
12 Mar 20
Registration statement (foreign) (amended)
5:15pm
F-1/A
c305klxp
6 Mar 20
Registration statement (foreign) (amended)
5:32pm
6-K
EX-99.1
qj8e9
28 Feb 20
Current report (foreign)
9:46am
6-K
EX-99.1
c6qflkrw6knk6 y4
19 Feb 20
Mereo BioPharma Announces Equity Investment of $3 Million from New U.S. Institutional Investor
9:32am
F-1
76d8u1uta hwwcxf92h
18 Feb 20
Registration statement (foreign)
5:15pm
6-K
EX-99.1
4dx1o51d ad4srcz
12 Feb 20
Mereo Biopharma Announces Update on Distribution Related to Contingent Value Rights Following Recent Oncologie Licensing Agreement for Navicixizumab
9:48am
6-K
EX-99.1
ytdsbo6m5h
10 Feb 20
Current report (foreign)
7:20am
6-K
EX-99.1
2un7c6o
14 Jan 20
Current report (foreign)
8:40am
6-K
EX-99.1
qday941ylrx3 cu
13 Jan 20
Mereo BioPharma and Oncologie Enter into Global Licensing Agreement for Navicixizumab
8:26am
6-K
EX-99.1
ps3j0ll6f8fq2 zd
22 Nov 19
Current report (foreign)
9:29am